[Hla-B27 gene: polymorphism, evolution, distribution, and association with spondyloartopathies]
1Klinika za urologiju, Klinicki bolnicki centar Zagreb, Kispatićeva 12, 10000 Zagreb. zgrubic@kbc-zagreb.hr
Reumatizam
|June 22, 2007
Summary
The human leukocyte antigen B27 (HLA-B27) gene is strongly linked to ankylosing spondylitis. This review explores its genetic variations, origins, spread, and proposed disease mechanisms.
Area of Science:
- Immunogenetics
- Rheumatology
- Molecular Biology
Context:
- The link between HLA-B27 and ankylosing spondylitis (AS) has been recognized for over 30 years.
- Despite extensive research, the precise pathogenic mechanisms remain incompletely understood.
Purpose:
- To provide a comprehensive overview of the current knowledge regarding HLA-B27 in relation to ankylosing spondylitis.
- To synthesize information on HLA-B27 polymorphism, evolutionary aspects, geographical distribution, and prevailing pathogenetic hypotheses.
Summary:
- This review examines the genetic diversity of HLA-B27, including its various alleles and their specific associations with AS.
- It discusses the evolutionary history and global distribution patterns of HLA-B27, highlighting potential selective pressures.
- Current hypotheses on how HLA-B27 contributes to the pathogenesis of AS, such as molecular mimicry and the unfolded protein response, are presented.
Impact:
- Enhances understanding of the genetic underpinnings of ankylosing spondylitis.
- Provides a foundation for future research into targeted therapies for HLA-B27-associated rheumatic diseases.
- Informs clinical practice regarding genetic risk assessment and personalized medicine approaches.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Multiple Allele Traits
The Concept of Multiple Allelism

